Výsledky vyhledávání - "Jyosen, Taiichiro"

Combination therapy with natural type human tumor necrosis factor (MHR-24) and human lymphoblastoid interferon-alpha (MOR-22) against renal cell carcinoma--a multiclinic cooperative, early phase II study. Subcommittee on Urogenital Malignancy, Committee on MHR-24 against Tumors

Autor: Niijima, Tadao, Akaza, Hideyuki, Koyanagi, Tomohiko, Togashi, Masaki, Kumamoto, Yoshiaki, Funyu, Tomihisa, Suzuki, Tadashi, Orikasa, Seiichi, Yoshikawa, Kazuyuki, Koiso, Kenkichi, Aso, Yoshiro, Honma, Yukio, Isurugi, Kouichiro, Yuge, Junji, Matsumura, Toshiyuki, Ishida, Yoshio, Nishimura, Youji, Nakauchi, Kouji, Nitou, Hiroshi, Fujita, Kimio, Kawamura, Takeshi, Kojima, Hiroyuki, Ishii, Yasunori, Tomoishi, Jyunzo, Mikata, Noriharu, Fukutani, Keiko, Oshima, Hiroyuki, Kakizoe, Tadao, Umeda, Takashi, Murahashi, Isao, Kitamura, Tadaichi, Tohma, Hiroshi, Ogawa, Akimi, Kawabe, Kazuki, Suzuki, Kazuo, Yoshida, Osamu, kakehi, Yoshiyuki, Kanamaru, Hiroshi, Kotake, Toshihiko, Miyagawa, Yukio, Ohmori, Hiroyuki, Matsumura, Yosuke, Nanba, Katsuichi, Jyosen, Taiichiro, Asahi, Toshihiko, Ike, Noriyuki, Usui, Tsuguru, Nakatsu, Hiroshi, Sakatoku, Jisaburo, Kagawa, Susumu, Fujita, Yukitoshi, Kumazawa, Jouichi, Naitou, Seiji, Saito, Yasushi, Ikegami, Keiichi, Ueda, Shoichi, Ohi, Yoshitada, Kawabata, Takashi

Publikováno v: 泌尿器科紀要. 38(10):1201-1207

全国多施設の共同研究により, 腎細胞癌に対するn-TNFとn-IFN-αの併用療法による有効性と安全性を検討した.1)腎細胞癌31例においてPRが4例認められ奏効率は12.9%であった.IFN-αが前治療に使�

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=jairo_______::2e86e64d5ef7b2d7a50d687d20251341
http://hdl.handle.net/2433/117663

Zobrazit plný text záznamu